[EN] TRANSGLUTAMINASE 2 (TG2) INHIBITORS<br/>[FR] INHIBITEURS DE TRANSGLUTAMINASE 2 (TG2)
申请人:SITARI PHARMA INC
公开号:WO2020033784A1
公开(公告)日:2020-02-13
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.
Tandem Radical Decarboxylation−Oxidation of Amino Acids: A Mild and Efficient Method for the Generation of <i>N</i>-Acyliminium Ions and Their Nucleophilic Trapping
作者:Alicia Boto、Rosendo Hernández、Ernesto Suárez
DOI:10.1021/jo000356t
日期:2000.8.1
derivatives have been prepared in order to test the scope and diastereoselectivity of this method. These substrates were treated with iodosylbenzene or (diacetoxyiodo)benzene (DIB) and iodine in order to generate the corresponding carboxyl radical, which evolves by loss of carbon dioxide to produce a carbon radical which in turn undergoes oxidation to an N-acyliminium ion. This postulated intermediate